Expert Interview
Discussing the potential of Lilly's Peresolimab in treating Rheumatoid Arthritis with a focus on the Phase 2 trial data
Ticker(s): LLY, ANABInstitution: Medical College of Wisconsin
- Assistant Professor of Medicine, Medical Director of the Vasculitis program.
- Research interests include clinical trials in vasculitis and myositis, "big data" epidemiology, and meta-research.
- Associate editor of the journal Rheumatology and hosts the Evidence Based Rheumatology podcast.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
